Course Description
One of the reasons the Health Insurance and Portability and Accountability Act of 1996 (HIPAA) was established was to protect a patient's health information and to maintain patient confidentiality and autonomy. It is the responsibility of radiologic technologists (RTs), as well as any healthcare provider, to adhere to HIPAA laws and regulations, as well as be aware of any additions or updates to them in their everyday practice and in regards to evolving technology. The American Registry of Radiologic Technologists (ARRT) as well as the American Society of Radiologic Technologists (ASRT) have developed a Code of Ethics and Standards of Ethics, respectively, that encourage compliance with HIPAA guidelines for protecting patients' health information. In order to uphold them both, RTs of all modalities should be well versed with such regulations and changes to the law. All members of the healthcare team should also be thoroughly educated about the seriousness of violating HIPAA laws and the consequences they may suffer for failing to do so. This course will review and clarify HIPAA regulations, including all aspects of the law that pertain to the healthcare environment. It will also describe how HIPPA laws and updates apply to evolving technology in the medical field, particularly during the COVID-19 pandemic and the resulting evolution of telemedicine. All HIPAA updates that have been necessary in order to comply with today's ever changing and improving electronic technology will also be addressed.

Learning Objectives
After completing this course, the participant should be able to:

• OUTLINE Health Insurance and Portability and Accountability Act of 1996 (HIPAA) guidelines and updates to them and how they affect the ability to maintain patient confidentiality in healthcare today.
• EXPLAIN the obligations and expectations of RTs and healthcare workers as they pertain to HIPAA, the American Registry of Radiologic Technologists (ARRT), and the American Society of Radiologic Technologists (ASRT).
• INTERPRET the role of HIPAA in telemedicine and the digital age, especially during and after the COVID-19 pandemic.
• EXPLAIN how HIPAA guidelines and updates to them continue to improve healthcare management while maintaining patient confidentiality and positive outcomes.
• SUMMARIZE the importance of educating all RTs, healthcare providers, and staff in HIPAA regulations, guidelines, and potential violations.
• RECALL potential violations and consequences that may occur as a result of a breach in HIPAA rules and regulations.
• SUMMARIZE the ways in which technology is used in picture archiving and communication systems (PACS) to secure radiological images and patient information.
• EXPLAIN the ways in which RTs can take steps in their daily workflow to maintain security of patients' sensitive health information and medical records.

In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.

Submit the completed answers to determine if you have passed the post-test assessment. You must answer 15 out of 20 questions correctly to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.

Participants successfully completing the activity content and passing the post-test will receive 2.0 ARRT Category A credits.

Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

Approved by the state of Florida for ARRT Category A credit.

Texas indirect credit.

This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

For ACCME Credit Provided by AKH Inc.

Release Date: 12/14/2022

Expiration Date: 12/14/2024

Target Audience
This activity is designed to meet the needs of Radiologic Technologists and Physicians, specifically Radiologists/

Criteria for Success
In order to receive credit, participants should complete the pre-test, review the content, and continue to the post-test and evaluation. A certificate will generate upon successful submission of the post-test and evaluation. If you have questions about this CME activity, please contact AKH Inc. at wendi@akhcme.com.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.  This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated.

Commercial Support
There is no commercial support for this activity.

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.

Disclosure of Unlabeled Use and Investigational Products
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.